Enterprise Connect Schedule
Generative AI Cost Conundrum: Unpacking ROI and Extracting Business Value
Derek Top (Principal Analyst & Research Director, Opus Research)
Andrew Benson (Chief Innovation Officer, Envision Radiology)
Gary LaSasso (Senior Director, Global IT Innovation, Amicus Therapeutics)
Abe Pursell (VP of Partnerships at Deepgram, Deepgram)
Location: Sun A
Date: Wednesday, March 19
Time: 3:15 pm - 4:00 pm
Session Type: Conference Track Session
Track: AI & Automation
Vault Recording: TBD
As GenAI continues to gain industry momentum, its true potential lies in the delivering tangible business value. The ultimate measure of success will be determined by the transformative impact of GenAI initiatives on organizational performance and operational efficiencies. So where are we in terms of actually achieving this impact? In this session, Opus Research and a panel of enterprise decision-makers guides attendees through the strategic benefits they've seen in of integrating Large Language Models (LLMs) into customer and employee workflows and deploying AI-based applications. We explore how organizations can leverage these tools to enhance productivity, improve customer experiences, and drive innovation. Our focus will be on helping you understand and maximize the business value of these technologies.
Key Topics:
- Boosting Efficiencies: Analyze the potential of GenAI to streamline processes, automate routine tasks, and increase employee productivity.
- Value-Driven Deployment: Identify high-impact areas for GenAI implementation that align with business objectives and maximize ROI.
- Risk Mitigation: Explore measures to reduce financial risks associated with GenAI adoption.
- Pricing Evolution: Assess the current state and future trajectory of LLM pricing and subscription models.